Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
Gut and Liver · 2023
DOI: 10.5009/gnl230070 ↗Kurz gefasst
Editorial in der Zeitschrift Gut and Liver, 2023. Verfasst von Jonggi Choi. Beteiligte Einrichtung: Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science and ICT, South Korea, National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
ORCID-Profile: Jonggi Choi
Förderung
- Ministry of Science and ICT, South Korea
- National Research Foundation of Korea
Zitieren
APA
Choi, J. (2023). Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B. Gut and Liver. https://doi.org/10.5009/gnl230070
Vancouver
Choi J. Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B. Gut and Liver. 2023. doi:10.5009/gnl230070
BibTeX
@article{Choi2023,
author = {Choi, Jonggi},
title = {Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B},
journal = {Gut and Liver},
year = {2023},
doi = {10.5009/gnl230070}
}
EUVIMED